What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
Henry S. Friedman mostly deals with Internal medicine, Glioma, Cancer research, Chemotherapy and Surgery.
His Internal medicine research incorporates elements of Gastroenterology and Oncology.
His Glioma study incorporates themes from Survival rate, Pathology, ATRX, Alkyltransferase and Telomerase reverse transcriptase.
His work carried out in the field of Cancer research brings together such families of science as Mutation, Tyrosine kinase, Gene duplication and Epidermal growth factor receptor.
As part of one scientific family, Henry S. Friedman deals mainly with the area of Chemotherapy, narrowing it down to issues related to the Toxicity, and often Complication and Pharmacokinetics.
He works mostly in the field of Surgery, limiting it down to topics relating to Clinical trial and, in certain cases, Randomized controlled trial.
His most cited work include:
- IDH1 and IDH2 Mutations in Gliomas (3746 citations)
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma (1837 citations)
- Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme (1184 citations)
What are the main themes of his work throughout his whole career to date?
Henry S. Friedman mainly focuses on Internal medicine, Glioma, Chemotherapy, Oncology and Surgery.
His work on Bevacizumab, Temozolomide and Phases of clinical research as part of general Internal medicine research is frequently linked to Irinotecan, thereby connecting diverse disciplines of science.
His study explores the link between Glioma and topics such as Pathology that cross with problems in Astrocytoma.
The Chemotherapy study combines topics in areas such as Medulloblastoma, Radiation therapy, Toxicity and Pharmacology.
His Oncology research includes elements of Cancer and Glioblastoma.
Many of his studies on Surgery apply to Clinical trial as well.
He most often published in these fields:
- Internal medicine (37.13%)
- Glioma (28.88%)
- Chemotherapy (26.40%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (37.13%)
- Oncology (25.08%)
- Glioma (28.88%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Oncology, Glioma, Bevacizumab and Glioblastoma.
His is doing research in Temozolomide, Chemotherapy, Adverse effect, Chemotherapy regimen and Cancer, both of which are found in Internal medicine.
He interconnects Gastroenterology, Stem cell and Immunology in the investigation of issues within Chemotherapy.
His research in Oncology intersects with topics in Phases of clinical research, Dose escalation, Brain tumor, Recurrent glioblastoma and Radiation therapy.
His Glioma study is related to the wider topic of Cancer research.
Bevacizumab is a primary field of his research addressed under Surgery.
Between 2013 and 2021, his most popular works were:
- TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL (354 citations)
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients (280 citations)
- Recurrent glioblastoma treated with recombinant poliovirus (243 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
The scientist’s investigation covers issues in Internal medicine, Glioma, Oncology, Cancer research and Bevacizumab.
His Glioma research is multidisciplinary, incorporating perspectives in Oncolytic virus, IDH1, Pathology, Stem cell and Regulation of gene expression.
His biological study spans a wide range of topics, including Cancer, Phases of clinical research, Survival rate, Recurrent glioblastoma and Radiation therapy.
His Cancer research research integrates issues from Epidermal growth factor receptor, Mutation, ATRX, Telomerase and Epigenetics.
His Bevacizumab study is focused on Surgery in general.
His Chemotherapy study frequently draws connections between related disciplines such as Gastroenterology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
